FTLF vs IH
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
FTLF exhibits a precarious financial profile characterized by a stable but mediocre Piotroski F-Score of 4/9 and a current price ($9.87) that significantly exceeds both its Graham Number ($8.12) and Intrinsic Value ($4.41). While revenue growth is explosive at 72.6%, this has failed to translate into bottom-line success, as evidenced by a -23.8% YoY earnings decline and a consistent track record of missing analyst estimates. The stock is in a severe technical downtrend, losing over 51% of its value in the last six months, suggesting a market repricing of its growth prospects.
iHuman Inc. presents a classic deep-value paradox: it possesses a stable Piotroski F-Score of 6/9 and an exceptionally clean balance sheet, yet it is plagued by severe growth decay. While the stock trades at a significant discount to its Graham Number ($4.08) and book value (P/B 0.61), the negative YoY revenue (-18.10%) and earnings (-33.30%) growth suggest a value trap. The current price of $1.74 is slightly below the growth-based intrinsic value of $1.82, but the bearish technical trend and weak insider sentiment offset the valuation appeal.
Compare Another Pair
Related Comparisons
FTLF vs IH: Head-to-Head Comparison
This page compares FitLife Brands, Inc. (FTLF) and iHuman Inc. (IH) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.